Hisako Matsumoto Selected Research

Periostin

4/2021	Assessment of serum periostin level as a predictor of requirement for intensive treatment for type-2 inflammation in asthmatics in future: A follow-up study of the KiHAC cohort.
6/2020	Role of serum periostin in severe obstructive sleep apnea with albuminuria: an observational study.
5/2020	Role of serum periostin in the management of asthma and its comorbidities.
1/2019	Roles of Periostin in Asthma.
7/2017	Utility of serum periostin in combination with exhaled nitric oxide in the management of asthma.
2/2017	Staphylococcus aureus enterotoxin sensitization involvement and its association with the CysLTR1 variant in different asthma phenotypes.
1/2017	The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosis.
1/2016	Roles of Periostin in Respiratory Disorders.
9/2015	Recent developments regarding periostin in bronchial asthma.
12/2014	Using exhaled nitric oxide and serum periostin as a composite marker to identify severe/steroid-insensitive asthma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hisako Matsumoto Research Topics

Disease

69	Asthma (Bronchial Asthma) 05/2024 - 10/2003
22	Inflammation (Inflammations) 04/2022 - 04/2004
15	Cough 01/2023 - 04/2007
10	Airway Remodeling 05/2020 - 03/2008
9	Chronic Obstructive Pulmonary Disease (COPD) 09/2023 - 06/2004
5	Gastroesophageal Reflux (GERD) 01/2023 - 07/2008
5	Pneumonia (Pneumonitis) 01/2022 - 10/2010
4	Obesity 05/2023 - 11/2008
4	Rhinosinusitis 01/2023 - 05/2013
4	Respiratory Hypersensitivity 04/2022 - 01/2011
4	Obstructive Sleep Apnea 06/2020 - 04/2003
4	Chronic Cough 01/2019 - 03/2009
4	Cough-Variant Asthma 01/2012 - 03/2006
4	Respiratory Sounds (Crackle) 04/2009 - 03/2006
3	Overweight 03/2023 - 05/2020
3	Bronchiectasis 01/2023 - 04/2004
3	Respiratory Tract Diseases (Respiratory Tract Disease) 06/2020 - 01/2016
2	Atopic Dermatitis (Atopic Eczema) 01/2023 - 01/2017
2	Pressure Ulcer (Bedsore) 08/2022 - 02/2014
2	Confusion (Bewilderment) 01/2022 - 12/2021
2	Hypoxia (Hypoxemia) 12/2021 - 06/2020
2	COVID-19 09/2021 - 01/2021
2	Seasonal Allergic Rhinitis (Hay Fever) 04/2020 - 01/2014
2	Idiopathic Pulmonary Fibrosis 01/2017 - 01/2016
2	Fibrosis (Cirrhosis) 01/2016 - 09/2015
2	Sinusitis 08/2013 - 10/2007
2	Dyspnea (Shortness of Breath) 09/2011 - 04/2009
2	Chronic Kidney Failure (Chronic Renal Failure) 10/2005 - 11/2003
1	Emphysema 09/2023
1	Disseminated Intravascular Coagulation 05/2023
1	Nasal Polyps (Nasal Polyp) 01/2023
1	Bronchopneumonia 12/2022
1	Parkinson Disease (Parkinson's Disease) 08/2022
1	Critical Illness (Critically Ill) 07/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Drug-Related Side Effects and Adverse Reactions 10/2020
1	Albuminuria 06/2020

Drug/Important Bio-Agent (IBA)

27	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2024 - 07/2003
17	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2024 - 01/2011
14	PeriostinIBA 04/2021 - 08/2013
10	Immunoglobulin E (IgE)IBA 01/2024 - 04/2009
8	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2011
7	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2007
7	Omalizumab (Xolair)FDA Link 01/2021 - 05/2013
6	Bronchodilator Agents (Bronchodilators)IBA 07/2021 - 12/2008
6	Methacholine Chloride (Methacholine)FDA Link 10/2014 - 11/2006
5	SteroidsIBA 04/2022 - 10/2003
4	AllergensIBA 11/2014 - 10/2007
4	Capsaicin (Zostrix)FDA Link 01/2012 - 04/2007
3	Enterotoxins (Enterotoxin)IBA 01/2023 - 02/2017
3	dupilumabIBA 01/2023 - 01/2021
3	Monoclonal AntibodiesIBA 11/2022 - 10/2014
3	Antitussive Agents (Antitussives)FDA Link 01/2021 - 01/2012
3	CytokinesIBA 01/2021 - 01/2012
3	Interleukin-13IBA 01/2016 - 01/2012
2	Nonesterified Fatty Acids (NEFA)IBA 05/2023 - 06/2020
2	Citric Acid (Citrate)FDA LinkGeneric 01/2023 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 06/2020
2	Urea (Carbamide)FDA LinkGeneric 01/2022 - 12/2021
2	Salmeterol Xinafoate (Serevent)FDA Link 01/2017 - 09/2011
2	ProstaglandinsIBA 01/2017 - 01/2012
2	AcidsIBA 07/2016 - 07/2008
2	anti-IgE antibodiesIBA 01/2016 - 10/2014
2	Fluticasone (Cutivate)FDA LinkGeneric 10/2014 - 09/2011
2	montelukast (Singulair)FDA Link 03/2013 - 01/2012
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 05/2010 - 03/2008
2	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 04/2009 - 07/2008
2	PotassiumIBA 10/2005 - 11/2003
1	Immunoglobulins (Immunoglobulin)IBA 01/2024
1	N 30IBA 09/2023
1	palmitoleic acidIBA 05/2023
1	LipidsIBA 05/2023
1	Oleic Acid (Oleate)IBA 05/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2023
1	Dacarbazine (DIC)FDA LinkGeneric 05/2023
1	mepolizumabIBA 01/2023
1	Staphylococcal enterotoxin AIBA 01/2023
1	staphylococcal enterotoxin BIBA 01/2023
1	Levodopa (L Dopa)FDA LinkGeneric 08/2022
1	N-hydroxy-2-aminopyreneIBA 01/2022
1	Protein CIBA 01/2022
1	Serum AlbuminIBA 12/2021
1	SodiumIBA 07/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 06/2020
1	MacrolidesIBA 06/2020
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 06/2020

Therapy/Procedure

14	Therapeutics 11/2022 - 04/2003
5	Aftercare (After-Treatment) 01/2012 - 04/2003
4	Continuous Positive Airway Pressure 04/2008 - 04/2003
3	Nebulizers and Vaporizers (Inhaler) 09/2021 - 10/2007
2	Home Nursing (Nursing, Home) 01/2022 - 10/2010
2	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 12/2009 - 11/2004
1	Bronchial Thermoplasty 03/2023
1	Precision Medicine 01/2022
1	Activities of Daily Living (ADL) 09/2021
1	Physical Therapy Modalities (Physical Therapy Technique) 07/2021
1	Lung Transplantation 01/2021